Malignant tumors of temporal bone in Songklanagarind Hospital: management and results.
OBJECTIVE
To evaluate the clinical course and treatment in patients with carcinoma of temporal bone


METHODS
The authors retrospectively reviewed the patients treated for primary carcinoma of temporal bone in Otolaryngology Head and Neck Surgery department, at Songklanagarind Hospital between 2002 and 2013. Thirty-two patients, including 10 cancer ofpinna and 22 carcinoma of the External Auditory Canal (EAC), were included in this study. The treatment modality was lateral temporal bone resection and postoperative radiotherapy and palliative radiotherapy for advanced stage tumors (T4). Twelve patients were excluded due to difference in modality. Twenty patients remained in the study.


RESULTS
Twenty patients had carcinoma of EAC, early stage (T1, T2) 36.4% and late stage (T3, T4) 63.6%. The overall survival of this group was 46.9%. The median survival period was 22 months (0.286-0.769, 95% CI).


CONCLUSIONS
The complete resection is the treatment of choice in primary cancer of temporal bone. Postoperative radiotherapy for a microscopic residual tumor is highly recommended. The most important thing is early diagnosis.
Wandee
W
Khaimook
Yuvatiya
Y
Plodpai
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D004424:Ear Canal / Q000473:pathology*; D004428:Ear Neoplasms / Q000473:pathology / Q000628:therapy*; D005260:Female; D006761:Hospitals; D006801:Humans; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D018365:Neoplasm, Residual / Q000473:pathology; D012189:Retrospective Studies; D012888:Skull Neoplasms / Q000473:pathology / Q000628:therapy*; D013701:Temporal Bone / Q000473:pathology*